AU2019296855A1 - Application of composition of mannuronic diacid in treating diabetes - Google Patents

Application of composition of mannuronic diacid in treating diabetes Download PDF

Info

Publication number
AU2019296855A1
AU2019296855A1 AU2019296855A AU2019296855A AU2019296855A1 AU 2019296855 A1 AU2019296855 A1 AU 2019296855A1 AU 2019296855 A AU2019296855 A AU 2019296855A AU 2019296855 A AU2019296855 A AU 2019296855A AU 2019296855 A1 AU2019296855 A1 AU 2019296855A1
Authority
AU
Australia
Prior art keywords
mannuronic
composition
total weight
diacids
diacid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019296855A
Other languages
English (en)
Inventor
Jian Ding
Meiyu Geng
Xianliang Xin
Zhenqing ZHANG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Materia Medica of CAS
Shanghai Green Valley Pharmaceutical Co Ltd
Original Assignee
Shanghai Institute of Materia Medica of CAS
Shanghai Green Valley Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Materia Medica of CAS, Shanghai Green Valley Pharmaceutical Co Ltd filed Critical Shanghai Institute of Materia Medica of CAS
Publication of AU2019296855A1 publication Critical patent/AU2019296855A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU2019296855A 2018-06-29 2019-06-28 Application of composition of mannuronic diacid in treating diabetes Abandoned AU2019296855A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201810721304.5 2018-06-29
CN201810721304.5A CN110652526A (zh) 2018-06-29 2018-06-29 甘露糖醛二酸的组合物在治疗糖尿病中的应用
PCT/CN2019/093822 WO2020001644A1 (zh) 2018-06-29 2019-06-28 甘露糖醛二酸的组合物在治疗糖尿病中的应用

Publications (1)

Publication Number Publication Date
AU2019296855A1 true AU2019296855A1 (en) 2021-01-28

Family

ID=68985883

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2019296855A Abandoned AU2019296855A1 (en) 2018-06-29 2019-06-28 Application of composition of mannuronic diacid in treating diabetes

Country Status (7)

Country Link
US (1) US11406652B2 (https=)
EP (1) EP3815690A4 (https=)
JP (1) JP2021528459A (https=)
KR (1) KR20210038875A (https=)
CN (1) CN110652526A (https=)
AU (1) AU2019296855A1 (https=)
WO (1) WO2020001644A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112336742A (zh) * 2019-08-06 2021-02-09 上海绿谷制药有限公司 甘露糖醛酸寡糖治疗Th1主导相关疾病的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100501584B1 (ko) 2000-02-03 2005-07-18 (주)케이비피 저분자 폴리만유로네이트의 제조방법, 혈청지질개선제로서의 이의 신규 용도 및 이를 함유하는 기능성식품 및 건강 보조 식품
CN1562050A (zh) * 2004-03-24 2005-01-12 中国海洋大学 褐藻酸寡糖在抗痴呆、抗糖尿病中的应用
CN100508985C (zh) * 2004-03-24 2009-07-08 中国海洋大学 褐藻胶寡糖及其衍生物及其制备方法和用途
CN101889027B (zh) 2007-12-29 2013-05-01 于传兴 低分子量海藻酸及其盐、应用、制法及药物组合物、食品
KR20160116252A (ko) 2015-03-27 2016-10-07 전남대학교산학협력단 비환원성 말단의 불포화형 만뉴론산 올리고당 및 이를 유효성분으로 포함하는 조성물
PL3498722T3 (pl) * 2016-08-15 2021-09-20 Shanghai Green Valley Pharmaceutical Co., Ltd. Sposób przygotowania oligomerycznego dikwasu mannuronowego
JP6977059B2 (ja) * 2016-12-30 2021-12-08 シャンハイ、グリーン、バレー、ファーマスーティカル、カンパニー、リミテッドShanghai Green Valley Pharmaceutical Co., Ltd. マンヌロン二酸の組成物

Also Published As

Publication number Publication date
US20210322449A1 (en) 2021-10-21
WO2020001644A1 (zh) 2020-01-02
KR20210038875A (ko) 2021-04-08
CN110652526A (zh) 2020-01-07
US11406652B2 (en) 2022-08-09
EP3815690A1 (en) 2021-05-05
JP2021528459A (ja) 2021-10-21
EP3815690A4 (en) 2022-04-13

Similar Documents

Publication Publication Date Title
US12269838B2 (en) Composition of mannuronic diacid
US11406659B2 (en) Use of mannuronic diacid composition in treatment of inflammation
US11406652B2 (en) Use of mannuronic diacid composition in treatment of diabetes
US11406654B2 (en) Use of mannuronic diacid composition in treatment of Parkinson's disease
HK40016250A (en) Use of a composition of mannuronic diacids in the treatment of diabetes
HK40014917A (en) Use of a composition of oligomeric mannuronic diacid for treating parkinson's disease
US11406651B2 (en) Use of mannuronic diacid composition in treatment of vascular dementia
US11406653B2 (en) Use of mannuronic diacid composition in treatment of pain
NZ754947B2 (en) Composition of mannuronic diacid
HK40016532A (en) Composition of mannuronic diacid
HK40016532B (en) Composition of mannuronic diacid

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period